Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Neoplasms of the CNS

  Free Subscription


Articles published in J Neurosurg

Retrieve available abstracts of 208 articles:
HTML format



Single Articles


    July 2022
  1. GAO S, Jin L, Moliterno J, Corbin ZA, et al
    Impact of radiotherapy delay following biopsy for patients with unresected glioblastoma.
    J Neurosurg. 2022 Jul 29:1-11. doi: 10.3171/2022.5.JNS212761.
    PubMed     Abstract available


  2. KIM YJ, Moon KS, Jang WY, Jung TY, et al
    Contralateral subfrontal approach for tuberculum sellae meningioma: techniques and clinical outcomes.
    J Neurosurg. 2022 Jul 22:1-12. doi: 10.3171/2022.5.JNS212899.
    PubMed     Abstract available


  3. SOLARI D, d'Avella E, Agresta G, Catapano D, et al
    Endoscopic endonasal approach for infradiaphragmatic craniopharyngiomas: a multicentric Italian study.
    J Neurosurg. 2022 Jul 8:1-11. doi: 10.3171/2022.5.JNS212974.
    PubMed     Abstract available


  4. ABRAMOV I, Park MT, Belykh E, Dru AB, et al
    Intraoperative confocal laser endomicroscopy: prospective in vivo feasibility study of a clinical-grade system for brain tumors.
    J Neurosurg. 2022 Jul 8:1-11. doi: 10.3171/2022.5.JNS2282.
    PubMed     Abstract available


    May 2022
  5. CHOTAI S, Tang AR, McDermott JR, Guidry BS, et al
    Comparison of supratentorial meningioma resection outcomes by dural reconstruction technique.
    J Neurosurg. 2022 May 27:1-8. doi: 10.3171/2022.4.JNS22290.
    PubMed     Abstract available


  6. YU ZY, Chung MH, Wang PW, Wu YC, et al
    Letter to the Editor. Outcome of malignant meningioma.
    J Neurosurg. 2022 May 27:1. doi: 10.3171/2022.3.JNS22645.
    PubMed    


  7. NICHOLS NM, Hadjipanayis CG
    Editorial. Supramaximal resection of eloquent glioblastoma: a continued paradigm shift in neurosurgical oncology.
    J Neurosurg. 2022 May 27:1-3. doi: 10.3171/2022.3.JNS22564.
    PubMed    


  8. DI L, Shah AH, Mahavadi A, Eichberg DG, et al
    Radical supramaximal resection for newly diagnosed left-sided eloquent glioblastoma: safety and improved survival over gross-total resection.
    J Neurosurg. 2022 May 27:1-8. doi: 10.3171/2022.3.JNS212399.
    PubMed     Abstract available


  9. SNEED PK, Chan JW, Ma L, Braunstein SE, et al
    Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases.
    J Neurosurg. 2022 May 20:1-9. doi: 10.3171/2022.4.JNS212597.
    PubMed     Abstract available


    April 2022
  10. BETTAG C, Hussein A, Schatlo B, Barrantes-Freer A, et al
    Endoscope-assisted visualization of 5-aminolevulinic acid fluorescence in surgery for brain metastases.
    J Neurosurg. 2022 Apr 29:1-6. doi: 10.3171/2022.3.JNS212301.
    PubMed     Abstract available


  11. GARCIA JH, Morshed RA, Chung J, Millares Chavez MA, et al
    Factors associated with preoperative and postoperative seizures in patients undergoing resection of brain metastases.
    J Neurosurg. 2022 Apr 29:1-8. doi: 10.3171/2022.3.JNS212285.
    PubMed     Abstract available


  12. THOMANN P, Hani L, Vulcu S, Schutz A, et al
    Natural history of meningiomas: a serial volumetric analysis of 240 tumors.
    J Neurosurg. 2022 Apr 29:1-11. doi: 10.3171/2022.3.JNS212626.
    PubMed     Abstract available


  13. PARK HH, Yoo J, Oh HC, Cha YJ, et al
    Regrowth factors of WHO grade I skull base meningiomas following incomplete resection.
    J Neurosurg. 2022 Apr 22:1-10. doi: 10.3171/2022.3.JNS2299.
    PubMed     Abstract available


  14. CHO A, Medvedeva K, Kranawetter B, Untersteiner H, et al
    How to dose-stage large or high-risk brain metastases: an alternative two-fraction radiosurgical treatment approach.
    J Neurosurg. 2022 Apr 15:1-10. doi: 10.3171/2022.2.JNS212440.
    PubMed     Abstract available


  15. WANG Y, Pan C, Xie M, Zuo P, et al
    Adult diffuse intrinsic pontine glioma: clinical, radiological, pathological, molecular features, and treatments of 96 patients.
    J Neurosurg. 2022 Apr 8:1-11. doi: 10.3171/2022.2.JNS211920.
    PubMed     Abstract available


  16. KIM AA, Dono A, Khalafallah AM, Nettel-Rueda B, et al
    Early repeat resection for residual glioblastoma: decision-making among an international cohort of neurosurgeons.
    J Neurosurg. 2022 Apr 1:1-10. doi: 10.3171/2022.1.JNS211970.
    PubMed     Abstract available


  17. GOEL A, Shah A, Vutha R
    Letter to the Editor. En masse resection of gliomas.
    J Neurosurg. 2022 Apr 1:1-2. doi: 10.3171/2022.1.JNS22107.
    PubMed    


  18. CASTRO MRH, Magill ST, Morshed RA, Young JS, et al
    Facial pain and sensory outcomes following resection of tumors compressing the trigeminal nerve.
    J Neurosurg. 2021;136:1119-1127.
    PubMed     Abstract available


  19. KINOSHITA Y, Zomorodi AR, Friedman AH, Sato H, et al
    Retrolabyrinthine transsigmoid approach to complex parabrainstem tumors in the posterior fossa.
    J Neurosurg. 2021;136:1097-1102.
    PubMed     Abstract available


  20. HUNDLEY KN, Pait TG, Rodriguez A, Day JD, et al
    Dr. Louise Eisenhardt's personal notes: how she and Dr. Cushing collected data and followed patients.
    J Neurosurg. 2021;136:1173-1178.
    PubMed     Abstract available


  21. ROSENSTOCK T, Hani L, Grittner U, Schlinkmann N, et al
    Bicentric validation of the navigated transcranial magnetic stimulation motor risk stratification model.
    J Neurosurg. 2021;136:1194-1206.
    PubMed     Abstract available


    March 2022
  22. STRICKLAND BA, Wedemeyer M, Ruzevick J, Micko A, et al
    5-Aminolevulinic acid-enhanced fluorescence-guided treatment of high-grade glioma using angled endoscopic blue light visualization: technical case series with preliminary follow-up.
    J Neurosurg. 2022 Mar 18:1-9. doi: 10.3171/2022.1.JNS212562.
    PubMed     Abstract available


  23. KIM KM, Kim SM, Kang H, Ji SY, et al
    Preservation of language function by mapping the arcuate fasciculus using intraoperative corticocortical evoked potential under general anesthesia in glioma surgery.
    J Neurosurg. 2022 Mar 18:1-9. doi: 10.3171/2022.1.JNS212658.
    PubMed     Abstract available


  24. DE SWART ME, Muller DMJ, Ardon H, Balvers RK, et al
    Between-hospital variation in time to glioblastoma surgery: a report from the Quality Registry Neuro Surgery in the Netherlands.
    J Neurosurg. 2022 Mar 11:1-10. doi: 10.3171/2022.1.JNS212566.
    PubMed     Abstract available


  25. MAIER AD, Mirian C, Haslund-Vinding J, Bartek J, et al
    Granular clinical history and outcome in 51 patients with primary and secondary malignant meningioma.
    J Neurosurg. 2022 Mar 11:1-11. doi: 10.3171/2022.1.JNS212723.
    PubMed     Abstract available


  26. JIMENEZ AE, Cicalese KV, Chakravarti S, Porras JL, et al
    Social determinants of health and the prediction of 90-day mortality among brain tumor patients.
    J Neurosurg. 2022 Mar 11:1-9. doi: 10.3171/2022.1.JNS212829.
    PubMed     Abstract available


  27. JAKOLA AS, Pedersen LK, Skjulsvik AJ, Myrmel K, et al
    The impact of resection in IDH-mutant WHO grade 2 gliomas: a retrospective population-based parallel cohort study.
    J Neurosurg. 2022 Mar 4:1-8. doi: 10.3171/2022.1.JNS212514.
    PubMed     Abstract available


  28. MRAH S, Descoteaux M, Wager M, Bore A, et al
    Network-level prediction of set-shifting deterioration after lower-grade glioma resection.
    J Neurosurg. 2022 Mar 4:1-9. doi: 10.3171/2022.1.JNS212257.
    PubMed     Abstract available


  29. POMERANIEC IJ, Xu Z, Lee CC, Yang HC, et al
    Dose to neuroanatomical structures surrounding pituitary adenomas and the effect of stereotactic radiosurgery on neuroendocrine function: an international multicenter study.
    J Neurosurg. 2021;136:813-821.
    PubMed     Abstract available


  30. CEYLAN S, Sen HE, Ozsoy B, Ceylan EC, et al
    Endoscopic approach for giant pituitary adenoma: clinical outcomes of 205 patients and comparison of two proposed classification systems for preoperative prediction of extent of resection.
    J Neurosurg. 2021;136:786-800.
    PubMed     Abstract available


  31. LABIB MA, Zhao X, Houlihan LM, Abramov I, et al
    Comparative analysis of the combined petrosal and the pretemporal transcavernous anterior petrosal approach to the petroclival region.
    J Neurosurg. 2021;136:905-916.
    PubMed     Abstract available


  32. RICHE M, Marijon P, Amelot A, Bielle F, et al
    Severity, timeline, and management of complications after stereotactic brain biopsy.
    J Neurosurg. 2021;136:867-876.
    PubMed     Abstract available


  33. MATHIEU D, Kotecha R, Sahgal A, De Salles A, et al
    Stereotactic radiosurgery for secretory pituitary adenomas: systematic review and International Stereotactic Radiosurgery Society practice recommendations.
    J Neurosurg. 2021;136:801-812.
    PubMed     Abstract available


    February 2022
  34. SUERO MOLINA E, Black D, Kaneko S, Muther M, et al
    Double dose of 5-aminolevulinic acid and its effect on protoporphyrin IX accumulation in low-grade glioma.
    J Neurosurg. 2022 Feb 25:1-10. doi: 10.3171/2021.12.JNS211724.
    PubMed     Abstract available


  35. MATSUNAGA S, Shuto T, Serizawa T, Aoyagi K, et al
    Gamma Knife radiosurgery for metastatic brain tumors from ovarian cancer: histopathological analysis of survival and local control. A Japanese multi-institutional cooperative and retrospective cohort study.
    J Neurosurg. 2022 Feb 11:1-9. doi: 10.3171/2021.12.JNS212239.
    PubMed     Abstract available


  36. CHO A, Hennenberg J, Untersteiner H, Hirschmann D, et al
    Influence of temporal muscle thickness on the outcome of radiosurgically treated patients with brain metastases from non-small cell lung cancer.
    J Neurosurg. 2022 Feb 4:1-7. doi: 10.3171/2021.12.JNS212193.
    PubMed     Abstract available


  37. LEE WJ, Hong SD, Woo KI, Seol HJ, et al
    Endoscopic endonasal and transorbital approaches to petrous apex lesions.
    J Neurosurg. 2021;136:431-440.
    PubMed     Abstract available


  38. TOMIO R, Horiguchi T, Borghei-Razavi H, Tamura R, et al
    Anterior transpetrosal approach: experiences in 274 cases over 33 years. Technical variations, operated patients, and approach-related complications.
    J Neurosurg. 2021;136:413-421.
    PubMed     Abstract available


  39. ZHANG JJ, Liu YH, Tu MY, Wei K, et al
    Comparison of 1.0 g/kg of 20% mannitol initiated at different time points and effects on brain relaxation in patients with midline shift undergoing supratentorial tumor resection: a randomized controlled trial.
    J Neurosurg. 2021;136:350-357.
    PubMed     Abstract available


  40. ASHER AL, Khalafallah AM, Mukherjee D, Alvi MA, et al
    Launching the Quality Outcomes Database Tumor Registry: rationale, development, and pilot data.
    J Neurosurg. 2021;136:369-378.
    PubMed     Abstract available


  41. HARDESTY DA, Montaser A, Kreatsoulas D, Shah VS, et al
    Complications after 1002 endoscopic endonasal approach procedures at a single center: lessons learned, 2010-2018.
    J Neurosurg. 2021;136:393-404.
    PubMed     Abstract available


  42. SNYDER MH, Asuzu DT, Shaver DE, Vance ML, et al
    Routine postoperative fluid restriction to prevent syndrome of inappropriate antidiuretic hormone secretion after transsphenoidal resection of pituitary adenoma.
    J Neurosurg. 2021;136:405-412.
    PubMed     Abstract available


    January 2022
  43. CHEN WC, Lafreniere M, Phuong C, Liu SJ, et al
    Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors.
    J Neurosurg. 2022 Jan 21:1-7. doi: 10.3171/2021.10.JNS211886.
    PubMed     Abstract available


  44. MATHIESEN T, Haslund-Vinding J, Skjoth-Rasmussen J, Poulsgaard L, et al
    Letter to the Editor. Copenhagen grading of meningioma.
    J Neurosurg. 2022 Jan 21:1-3. doi: 10.3171/2021.10.JNS204467.
    PubMed    


  45. CASTLE-KIRSZBAUM M, Kam J, Dixon B, Goldschlager T, et al
    Surgical outcomes and longitudinal quality of life after endoscopic endonasal surgery for anterior skull base meningioma.
    J Neurosurg. 2022 Jan 14:1-8. doi: 10.3171/2021.11.JNS212090.
    PubMed     Abstract available


  46. MIJDERWIJK HJ, Nieboer D, Incekara F, Berger K, et al
    Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastoma.
    J Neurosurg. 2022 Jan 14:1-10. doi: 10.3171/2021.10.JNS211261.
    PubMed     Abstract available


  47. AL-HOLOU WN, Suki D, Hodges TR, Everson RG, et al
    Circumferential sulcus-guided resection technique for improved outcomes of low-grade gliomas.
    J Neurosurg. 2022 Jan 7:1-11. doi: 10.3171/2021.9.JNS21718.
    PubMed     Abstract available


  48. BROWN DA, Goyal A, Richter KR, Haglin JM, et al
    Clinical utility of brain biopsy for presumed CNS relapse of systemic lymphoma.
    J Neurosurg. 2021;136:30-39.
    PubMed     Abstract available


    December 2021
  49. YOO J, Yoon SJ, Kim KH, Jung IH, et al
    Patterns of recurrence according to the extent of resection in patients with IDH-wild-type glioblastoma: a retrospective study.
    J Neurosurg. 2021 Dec 31:1-11. doi: 10.3171/2021.10.JNS211491.
    PubMed     Abstract available


  50. BENJAMIN CG, Gurewitz J, Kavi A, Bernstein K, et al
    Survival and outcomes in patients with >/= 25 cumulative brain metastases treated with stereotactic radiosurgery.
    J Neurosurg. 2021 Dec 24:1-11. doi: 10.3171/2021.9.JNS21882.
    PubMed     Abstract available


  51. CHIOU GY, Chiang CL, Yang HC, Shen CI, et al
    Combined stereotactic radiosurgery and tyrosine kinase inhibitor therapy versus tyrosine kinase inhibitor therapy alone for the treatment of non-small cell lung cancer patients with brain metastases.
    J Neurosurg. 2021 Dec 17:1-8. doi: 10.3171/2021.9.JNS211373.
    PubMed     Abstract available


  52. YOMO S, Yako T, Kitazawa K, Oguchi K, et al
    Staged radiosurgery alone versus postoperative cavity radiosurgery for patients with midsize-to-large brain metastases: a propensity score matching analysis.
    J Neurosurg. 2021 Dec 17:1-8. doi: 10.3171/2021.9.JNS211797.
    PubMed     Abstract available


  53. SHIBAHARA I, Saito R, Kanamori M, Sonoda Y, et al
    Role of the parietooccipital fissure and its implications in the pathophysiology of posterior medial temporal gliomas.
    J Neurosurg. 2021 Dec 14:1-10. doi: 10.3171/2021.7.JNS21990.
    PubMed     Abstract available


  54. LONDON D, Patel DN, Donahue B, Navarro RE, et al
    The incidence and predictors of new brain metastases in patients with non-small cell lung cancer following discontinuation of systemic therapy.
    J Neurosurg. 2021 Dec 10:1-11. doi: 10.3171/2021.9.JNS212150.
    PubMed     Abstract available


  55. GADOT R, Khan AB, Patel R, Goethe E, et al
    Predictors of postoperative seizure outcome in supratentorial meningioma.
    J Neurosurg. 2021 Dec 10:1-10. doi: 10.3171/2021.9.JNS211738.
    PubMed     Abstract available


    November 2021
  56. MORSHED RA, Lee AT, Wang EJ, Young JS, et al
    Functional outcomes after resection of middle frontal gyrus diffuse gliomas.
    J Neurosurg. 2021 Nov 19:1-8. doi: 10.3171/2021.8.JNS211624.
    PubMed     Abstract available


  57. RAMOS-FRESNEDO A, Domingo RA, Sanchez-Garavito JE, Perez-Vega C, et al
    The impact of multiple lesions on progression-free survival of meningiomas: a 10-year multicenter experience.
    J Neurosurg. 2021 Nov 19:1-9. doi: 10.3171/2021.8.JNS211252.
    PubMed     Abstract available


  58. GOYAL A, Zreik J, Brown DA, Kerezoudis P, et al
    Disparities in access to surgery for glioblastoma multiforme at high-volume Commission on Cancer-accredited hospitals in the United States.
    J Neurosurg. 2021 Nov 12:1-10. doi: 10.3171/2021.7.JNS211307.
    PubMed     Abstract available


  59. BUNEVICIUS A, Pikis S, Kondziolka D, Patel DN, et al
    Stereotactic radiosurgery for glioblastoma considering tumor genetic profiles: an international multicenter study.
    J Neurosurg. 2021 Nov 5:1-9. doi: 10.3171/2021.7.JNS211277.
    PubMed     Abstract available


  60. MATHON B, Amelot A
    Letter to the Editor. The place of brain biopsy in patients with presumed CNS relapse of systemic lymphoma.
    J Neurosurg. 2021;136:933-934.
    PubMed    


    October 2021
  61. AVERY MB, Mallari RJ, Barkhoudarian G, Kelly DF, et al
    Supraorbital and mini-pterional keyhole craniotomies for brain tumors: a clinical and anatomical comparison of indications and outcomes in 204 cases.
    J Neurosurg. 2021 Oct 29:1-11. doi: 10.3171/2021.6.JNS21759.
    PubMed     Abstract available


  62. TRIPATHI S, Vivas-Buitrago T, Domingo RA, Biase G, et al
    IDH-wild-type glioblastoma cell density and infiltration distribution influence on supramarginal resection and its impact on overall survival: a mathematical model.
    J Neurosurg. 2021 Oct 29:1-9. doi: 10.3171/2021.6.JNS21925.
    PubMed     Abstract available


  63. JUNGER ST, Reinecke D, Meissner AK, Goldbrunner R, et al
    Resection of symptomatic non-small cell lung cancer brain metastasis in the setting of multiple brain metastases.
    J Neurosurg. 2021 Oct 29:1-7. doi: 10.3171/2021.7.JNS211172.
    PubMed     Abstract available


  64. WADIURA LI, Reichert D, Sperl V, Lang A, et al
    Influence of dexamethasone on visible 5-ALA fluorescence and quantitative protoporphyrin IX accumulation measured by fluorescence lifetime imaging in glioblastomas: is pretreatment obligatory before fluorescence-guided surgery?
    J Neurosurg. 2021 Oct 22:1-9. doi: 10.3171/2021.6.JNS21940.
    PubMed     Abstract available


  65. KHALAFALLAH AM, Rakovec M, Burapachaisri K, Fung S, et al
    The Suprasellar Meningioma Patient-Reported Outcome Survey: a disease-specific patient-reported outcome measure for resection of suprasellar meningioma.
    J Neurosurg. 2021;:9.
    PubMed     Abstract available


  66. GODIL SS, Tosi U, Gerges M, Garton ALA, et al
    Long-term tumor control after endoscopic endonasal resection of craniopharyngiomas: comparison of gross-total resection versus subtotal resection with radiation therapy.
    J Neurosurg. 2021 Oct 15:1-9. doi: 10.3171/2021.5.JNS202011.
    PubMed     Abstract available


  67. MOMIN AA, Soni P, Shao J, Nowacki AS, et al
    Adjuvant radiation versus observation with salvage radiation after gross-total resection of WHO grade II meningiomas: a propensity score-adjusted analysis.
    J Neurosurg. 2021 Oct 8:1-8. doi: 10.3171/2021.4.JNS21559.
    PubMed     Abstract available


  68. SCHUPPER AJ, Baron RB, Cheung W, Rodriguez J, et al
    5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study.
    J Neurosurg. 2021 Oct 8:1-10. doi: 10.3171/2021.5.JNS21310.
    PubMed     Abstract available


  69. POPADIC B, Scheichel F, Pinggera D, Weber M, et al
    The meningioma surface factor: a novel approach to quantify shape irregularity on preoperative imaging and its correlation with WHO grade.
    J Neurosurg. 2021 Oct 8:1-7. doi: 10.3171/2021.5.JNS204223.
    PubMed     Abstract available


  70. DUFFAU H
    Introducing the concept of brain metaplasticity in glioma: how to reorient the pattern of neural reconfiguration to optimize the therapeutic strategy.
    J Neurosurg. 2021 Oct 8:1-5. doi: 10.3171/2021.5.JNS211214.
    PubMed    


  71. YOUNG JS, Gogos AJ, Aabedi AA, Morshed RA, et al
    Resection of supplementary motor area gliomas: revisiting supplementary motor syndrome and the role of the frontal aslant tract.
    J Neurosurg. 2021 Oct 1:1-7. doi: 10.3171/2021.4.JNS21187.
    PubMed     Abstract available


  72. FISHER FL, Zamanipoor Najafabadi AH, van der Meer PB, Boele FW, et al
    Long-term health-related quality of life and neurocognitive functioning after treatment in skull base meningioma patients.
    J Neurosurg. 2021 Oct 1:1-13. doi: 10.3171/2021.4.JNS203891.
    PubMed     Abstract available


    September 2021
  73. SAITO T, Muragaki Y, Tamura M, Maruyama T, et al
    Awake craniotomy with transcortical motor evoked potential monitoring for resection of gliomas within or close to motor-related areas: validation of utility for predicting motor function.
    J Neurosurg. 2021 Sep 24:1-10. doi: 10.3171/2021.3.JNS21374.
    PubMed     Abstract available


  74. MEDIKONDA R, Patel K, Jackson C, Saleh L, et al
    The safety and efficacy of dexamethasone in the perioperative management of glioma patients.
    J Neurosurg. 2021 Sep 24:1-8. doi: 10.3171/2021.4.JNS204127.
    PubMed     Abstract available


  75. ASUZU DT, Bunevicius A, Kormath Anand R, Suleiman M, et al
    Clinical and radiologic outcomes after stereotactic radiosurgery for meningiomas in direct contact with the optic apparatus: an international multicenter study.
    J Neurosurg. 2021 Sep 24:1-7. doi: 10.3171/2021.3.JNS21328.
    PubMed     Abstract available


  76. HAMDAN N, Duffau H
    Extending the multistage surgical strategy for recurrent initially low-grade gliomas: functional and oncological outcomes in 31 consecutive patients who underwent a third resection under awake mapping.
    J Neurosurg. 2021 Sep 10:1-10. doi: 10.3171/2021.3.JNS21264.
    PubMed     Abstract available


  77. CARNEVALE JA, Imber BS, Winston GM, Goldberg JL, et al
    Risk of tract recurrence with stereotactic biopsy of brain metastases: an 18-year cancer center experience.
    J Neurosurg. 2021 Sep 10:1-7. doi: 10.3171/2021.3.JNS204347.
    PubMed     Abstract available


    August 2021
  78. SHIMIZU Y, Gumin J, Gao F, Hossain A, et al
    Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma.
    J Neurosurg. 2021 Aug 27:1-11. doi: 10.3171/2021.3.JNS203045.
    PubMed     Abstract available


  79. MORSHED RA, Jiam NT, Wang EJ, Magill ST, et al
    Posterior petrous face meningiomas presenting with Meniere's-like syndrome: a case series and review of the literature.
    J Neurosurg. 2021 Aug 27:1-8. doi: 10.3171/2021.2.JNS203259.
    PubMed     Abstract available


  80. BENJAMIN CG, Schnurman Z, Ashayeri K, Kazi E, et al
    Volumetric growth rates of untreated cavernous sinus meningiomas.
    J Neurosurg. 2021 Aug 20:1-8. doi: 10.3171/2021.2.JNS203485.
    PubMed     Abstract available


  81. MEDIKONDA R, Choi J, Pant A, Saleh L, et al
    Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma.
    J Neurosurg. 2021 Aug 13:1-10. doi: 10.3171/2021.1.JNS202482.
    PubMed     Abstract available


  82. SPINA A, Boari N, Mortini P
    Letter to the Editor. Management of hyperostotic spheno-orbital meningiomas.
    J Neurosurg. 2021 Aug 13:1-2. doi: 10.3171/2021.4.JNS21952.
    PubMed    


  83. MICKO A, Agam MS, Brunswick A, Strickland BA, et al
    Treatment strategies for giant pituitary adenomas in the era of endoscopic transsphenoidal surgery: a multicenter series.
    J Neurosurg. 2021 Aug 13:1-10. doi: 10.3171/2021.1.JNS203982.
    PubMed     Abstract available


  84. CHUANG JM, Hueng DY
    Letter to the Editor. Treatment of MGMT-positive glioblastoma.
    J Neurosurg. 2021 Aug 6:1. doi: 10.3171/2021.3.JNS21571.
    PubMed    


  85. ROMERO-GARCIA R, Suckling J, Owen M, Assem M, et al
    Memory recovery in relation to default mode network impairment and neurite density during brain tumor treatment.
    J Neurosurg. 2021 Aug 6:1-11. doi: 10.3171/2021.1.JNS203959.
    PubMed     Abstract available


    July 2021
  86. AMMANUEL SG, Almeida NC, Kurteff G, Kakaizada S, et al
    Correlation of natural language assessment results with health-related quality of life in adult glioma patients.
    J Neurosurg. 2021 Jul 30:1-7. doi: 10.3171/2021.1.JNS203387.
    PubMed     Abstract available


  87. LAD M, Gupta R, Raman A, Parikh N, et al
    Trends in physician reimbursements and procedural volumes for radiosurgery versus open surgery in brain tumor care: an analysis of Medicare data from 2009 to 2018.
    J Neurosurg. 2021 Jul 30:1-12. doi: 10.3171/2020.11.JNS202284.
    PubMed     Abstract available


  88. SILVA LL, Tuncer MS, Vajkoczy P, Picht T, et al
    Distinct approaches to language pathway tractography: comparison of anatomy-based, repetitive navigated transcranial magnetic stimulation (rTMS)-based, and rTMS-enhanced diffusion tensor imaging-fiber tracking.
    J Neurosurg. 2021 Jul 30:1-12. doi: 10.3171/2020.12.JNS204028.
    PubMed     Abstract available


  89. HAMIDI N, Karmur B, Sperrazza S, Alexieva J, et al
    Guidelines for optimal utilization of social media for brain tumor stakeholders.
    J Neurosurg. 2021 Jul 23:1-8. doi: 10.3171/2020.11.JNS203226.
    PubMed     Abstract available


  90. ULGEN E, Aras FK, Cosgun E, Ersen-Danyeli A, et al
    Correlation of anatomical involvement patterns of insular gliomas with subnetworks of the limbic system.
    J Neurosurg. 2021 Jul 23:1-12. doi: 10.3171/2020.12.JNS203652.
    PubMed     Abstract available


  91. ASANO K, Hasegawa S, Matsuzaka M, Ohkuma H, et al
    Brain tumor-related epilepsy and risk factors for metastatic brain tumors: analysis of 601 consecutive cases providing real-world data.
    J Neurosurg. 2021 Jul 16:1-12. doi: 10.3171/2020.11.JNS202873.
    PubMed     Abstract available


  92. NEMAN J, Franklin M, Madaj Z, Deshpande K, et al
    Use of predictive spatial modeling to reveal that primary cancers have distinct central nervous system topography patterns of brain metastasis.
    J Neurosurg. 2021 Jul 16:1-9. doi: 10.3171/2021.1.JNS203536.
    PubMed     Abstract available


  93. MULLER DMJ, Robe PA, Ardon H, Barkhof F, et al
    On the cutting edge of glioblastoma surgery: where neurosurgeons agree and disagree on surgical decisions.
    J Neurosurg. 2021 Jul 9:1-11. doi: 10.3171/2020.11.JNS202897.
    PubMed     Abstract available


  94. LI L, Fang S, Li G, Zhang K, et al
    Glioma-related epilepsy in patients with diffuse high-grade glioma after the 2016 WHO update: seizure characteristics, risk factors, and clinical outcomes.
    J Neurosurg. 2021 Jul 9:1-9. doi: 10.3171/2020.12.JNS203351.
    PubMed     Abstract available


  95. CHAN AY, Choi EH, Oh MY, Vadera S, et al
    Elective versus nonelective brain tumor resections: a 5-year propensity score matching cost comparison analysis.
    J Neurosurg. 2021 Jul 9:1-5. doi: 10.3171/2020.12.JNS203401.
    PubMed     Abstract available


    June 2021
  96. ROSSI M, Puglisi G, Conti Nibali M, Vigano L, et al
    Asleep or awake motor mapping for resection of perirolandic glioma in the nondominant hemisphere? Development and validation of a multimodal score to tailor the surgical strategy.
    J Neurosurg. 2021 Jun 18:1-14. doi: 10.3171/2020.11.JNS202715.
    PubMed     Abstract available


  97. MOHAMMED N, Hung YC, Xu Z, Chytka T, et al
    Neurofibromatosis type 2-associated meningiomas: an international multicenter study of outcomes after Gamma Knife stereotactic radiosurgery.
    J Neurosurg. 2021 Jun 18:1-6. doi: 10.3171/2020.12.JNS202814.
    PubMed     Abstract available


  98. KANEKO S, Suero Molina E, Sporns P, Schipmann S, et al
    Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma.
    J Neurosurg. 2021 Jun 18:1-7. doi: 10.3171/2020.10.JNS202881.
    PubMed     Abstract available


  99. SHAH PP, Franke JL, Medikonda R, Jackson CM, et al
    Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy.
    J Neurosurg. 2021 Jun 4:1-11. doi: 10.3171/2020.10.JNS201787.
    PubMed     Abstract available


  100. DELLA PEPA GM, D'Alessandris QG, Burattini B, Quaranta D, et al
    Letter to the Editor. Exploring cognitive functions in low-grade glioma surgery.
    J Neurosurg. 2021 Jun 4:1-2. doi: 10.3171/2021.2.JNS21186.
    PubMed    


  101. VIVAS-BUITRAGO T, Domingo RA, Tripathi S, De Biase G, et al
    Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma.
    J Neurosurg. 2021 Jun 4:1-8. doi: 10.3171/2020.10.JNS203366.
    PubMed     Abstract available


    May 2021
  102. ROTH O'BRIEN DA, Kaye SM, Poppas PJ, Mahase SS, et al
    Time to administration of stereotactic radiosurgery to the cavity after surgery for brain metastases: a real-world analysis.
    J Neurosurg. 2021 May 28:1-11. doi: 10.3171/2020.10.JNS201934.
    PubMed     Abstract available


  103. BABA A, Saha A, McCradden MD, Boparai K, et al
    Development and validation of a patient-centered, meningioma-specific quality-of-life questionnaire.
    J Neurosurg. 2021 May 14:1-10. doi: 10.3171/2020.11.JNS201761.
    PubMed     Abstract available


  104. QIAO N, Yang X, Li C, Ma G, et al
    The predictive value of intraoperative visual evoked potential for visual outcome after extended endoscopic endonasal surgery for adult craniopharyngioma.
    J Neurosurg. 2021 May 7:1-11. doi: 10.3171/2020.10.JNS202779.
    PubMed     Abstract available


    March 2021
  105. FAN J, Liu Y, Pan J, Peng Y, et al
    Endoscopic endonasal versus transcranial surgery for primary resection of craniopharyngiomas based on a new QST classification system: a comparative series of 315 patients.
    J Neurosurg. 2021 Mar 5:1-12. doi: 10.3171/2020.7.JNS20257.
    PubMed     Abstract available


  106. MAGILL ST, Jane JA, Prevedello DM
    Editorial. Craniopharyngioma classification.
    J Neurosurg. 2021 Mar 5:1-3. doi: 10.3171/2020.8.JNS202666.
    PubMed    


  107. FONSECA A, Solano P, Ramaswamy V, Tabori U, et al
    Ventricular size determination and management of ventriculomegaly and hydrocephalus in patients with diffuse intrinsic pontine glioma: an institutional experience.
    J Neurosurg. 2021 Mar 5:1-7. doi: 10.3171/2020.10.JNS203257.
    PubMed     Abstract available


  108. TENG CW, Cho SS, Singh Y, De Ravin E, et al
    Second window ICG predicts gross-total resection and progression-free survival during brain metastasis surgery.
    J Neurosurg. 2021 Mar 2:1-10. doi: 10.3171/2020.8.JNS201810.
    PubMed     Abstract available


    February 2021
  109. MORISAKO H, Ohata H, Shinde B, Nagahama A, et al
    Minimal anterior and posterior combined transpetrosal approach for large petroclival meningiomas.
    J Neurosurg. 2021 Feb 19:1-10. doi: 10.3171/2020.8.JNS202060.
    PubMed     Abstract available


  110. RAPOPORT BI, McDermott MW, Schwartz TH
    Letter to the Editor. Time to move beyond the Simpson scale in meningioma surgery.
    J Neurosurg. 2021 Feb 19:1-2. doi: 10.3171/2020.12.JNS204213.
    PubMed    


    January 2021
  111. MAGILL ST, Nguyen MP, Aghi MK, Theodosopoulos PV, et al
    Postoperative diffusion-weighted imaging and neurological outcome after convexity meningioma resection.
    J Neurosurg. 2021 Jan 29:1-8. doi: 10.3171/2020.8.JNS193537.
    PubMed     Abstract available


  112. MOTOMURA K, Chalise L, Shimizu H, Yamaguchi J, et al
    Intraoperative seizure outcome of levetiracetam combined with perampanel therapy in patients with glioma undergoing awake brain surgery.
    J Neurosurg. 2021 Jan 22:1-10. doi: 10.3171/2020.8.JNS201400.
    PubMed     Abstract available


  113. YOUNG JS, Gogos AJ, Pereira MP, Morshed RA, et al
    Effects of ventricular entry on patient outcome during glioblastoma resection.
    J Neurosurg. 2021 Jan 8:1-9. doi: 10.3171/2020.7.JNS201362.
    PubMed     Abstract available


  114. BUNEVICIUS A, Suleiman M, Patel S, Martinez Alvarez R, et al
    Stereotactic radiosurgery for treatment of radiation-induced meningiomas: a multiinstitutional study.
    J Neurosurg. 2021 Jan 1:1-9. doi: 10.3171/2020.7.JNS202064.
    PubMed     Abstract available


    December 2020
  115. STOGBAUER L, Thomas C, Wagner A, Warneke N, et al
    Efficacy of decitabine in malignant meningioma cells: relation to promoter demethylation of distinct tumor suppressor and oncogenes and independence from TERT.
    J Neurosurg. 2020 Dec 11:1-10. doi: 10.3171/2020.7.JNS193097.
    PubMed     Abstract available


  116. KENNEDY WR, DeWees TA, Acharya S, Mahmood M, et al
    Internal dose escalation associated with increased local control for melanoma brain metastases treated with stereotactic radiosurgery.
    J Neurosurg. 2020 Dec 11:1-7. doi: 10.3171/2020.7.JNS192210.
    PubMed     Abstract available


  117. GUPTE TP, Li C, Jin L, Yalcin K, et al
    Clinical and genomic factors associated with seizures in meningiomas.
    J Neurosurg. 2020 Dec 4:1-10. doi: 10.3171/2020.7.JNS201042.
    PubMed     Abstract available


  118. NG S, Herbet G, Lemaitre AL, Cochereau J, et al
    Neuropsychological assessments before and after awake surgery for incidental low-grade gliomas.
    J Neurosurg. 2020 Dec 4:1-10. doi: 10.3171/2020.7.JNS201507.
    PubMed     Abstract available


    November 2020
  119. GOGOS AJ
    Erratum. Triple motor mapping: transcranial, bipolar, and monopolar mapping for supratentorial glioma resection adjacent to motor pathways.
    J Neurosurg. 2020 Nov 27:1. doi: 10.3171/2020.10.JNS193434.
    PubMed    


  120. YOO DH, Sohn CH, Cho YD, Kang HS, et al
    Superselective pseudocontinuous arterial spin labeling in patients with meningioma: utility in prediction of feeding arteries and preoperative embolization feasibility.
    J Neurosurg. 2020 Nov 13:1-7. doi: 10.3171/2020.7.JNS201915.
    PubMed     Abstract available


  121. MIYOSHI K, Wada T, Uwano I, Sasaki M, et al
    Predicting the consistency of intracranial meningiomas using apparent diffusion coefficient maps derived from preoperative diffusion-weighted imaging.
    J Neurosurg. 2020 Nov 13:1-8. doi: 10.3171/2020.6.JNS20740.
    PubMed     Abstract available


    October 2020
  122. PRZYBYLOWSKI CJ, Hendricks BK, Frisoli FA, Zhao X, et al
    Prognostic value of the Simpson grading scale in modern meningioma surgery: Barrow Neurological Institute experience.
    J Neurosurg. 2020 Oct 23:1-9. doi: 10.3171/2020.6.JNS20374.
    PubMed     Abstract available


  123. CHICOINE MR, Yahanda AT, Dacey RG
    A tribute to the late Professor Donald Simpson, Australian neurosurgeon and namesake of the Simpson grading system for meningioma extent of resection.
    J Neurosurg. 2020 Oct 23:1-7. doi: 10.3171/2020.6.JNS201331.
    PubMed     Abstract available


  124. SHAH AS, Sylvester PT, Yahanda AT, Vellimana AK, et al
    Intraoperative MRI for newly diagnosed supratentorial glioblastoma: a multicenter-registry comparative study to conventional surgery.
    J Neurosurg. 2020 Oct 9:1-10. doi: 10.3171/2020.6.JNS19287.
    PubMed     Abstract available


  125. SELLIER A, Moritz-Gasser S, Lemaitre AL, Herbet G, et al
    Presence of a translator in the operating theater for awake mapping in foreign patients with low-grade glioma: a surgical experience based on 18 different native languages.
    J Neurosurg. 2020 Oct 9:1-9. doi: 10.3171/2020.6.JNS201071.
    PubMed     Abstract available


  126. GOGOS AJ, Young JS, Pereira MP, Morshed RA, et al
    Surgical management of incidentally discovered low-grade gliomas.
    J Neurosurg. 2020 Oct 2:1-8. doi: 10.3171/2020.6.JNS201296.
    PubMed     Abstract available


  127. LIVERMORE LJ, Isabelle M, Bell IM, Edgar O, et al
    Raman spectroscopy to differentiate between fresh tissue samples of glioma and normal brain: a comparison with 5-ALA-induced fluorescence-guided surgery.
    J Neurosurg. 2020 Oct 2:1-11. doi: 10.3171/2020.5.JNS20376.
    PubMed     Abstract available


    September 2020
  128. NAVARRIA P, Pessina F, Clerici E, Rossini Z, et al
    Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series.
    J Neurosurg. 2020 Sep 4:1-14. doi: 10.3171/2020.5.JNS201116.
    PubMed     Abstract available


    August 2020
  129. WANG L, Chen J
    Letter to the Editor. Feasibility and safety of supratotal resection for low-grade gliomas.
    J Neurosurg. 2020 Aug 28:1-2. doi: 10.3171/2020.7.JNS202601.
    PubMed    


  130. KHALAFALLAH AM, Huq S, Jimenez AE, Brem H, et al
    The 5-factor modified frailty index: an effective predictor of mortality in brain tumor patients.
    J Neurosurg. 2020 Aug 14:1-9. doi: 10.3171/2020.5.JNS20766.
    PubMed     Abstract available


    July 2020
  131. STRICKLAND BA, Wedemeyer M, Sizdahkhani S, Giannotta SL, et al
    Letter to the Editor. Management of petroclival meningioma.
    J Neurosurg. 2020 Jul 31:1-3. doi: 10.3171/2020.3.JNS20599.
    PubMed    


  132. YOUNGERMAN BE, Banu MA, Gerges MM, Odigie E, et al
    Endoscopic endonasal approach for suprasellar meningiomas: introduction of a new scoring system to predict extent of resection and assist in case selection with long-term outcome data.
    J Neurosurg. 2020 Jul 24:1-13. doi: 10.3171/2020.4.JNS20475.
    PubMed     Abstract available


  133. FUKUI N, Yawata T, Nakajo T, Kawanishi Y, et al
    Targeting CD146 using folic acid-conjugated nanoparticles and suppression of tumor growth in a mouse glioma model.
    J Neurosurg. 2020 Jul 24:1-11. doi: 10.3171/2020.4.JNS193078.
    PubMed     Abstract available


  134. SPILLE DC, Hess K, Bormann E, Sauerland C, et al
    Risk of tumor recurrence in intracranial meningiomas: comparative analyses of the predictive value of the postoperative tumor volume and the Simpson classification.
    J Neurosurg. 2020 Jul 17:1-8. doi: 10.3171/2020.4.JNS20412.
    PubMed     Abstract available


  135. BUNEVICIUS A, Lavezzo K, Shabo L, McClure J, et al
    Quality-of-life trajectories after stereotactic radiosurgery for brain metastases.
    J Neurosurg. 2020 Jul 10:1-9. doi: 10.3171/2020.4.JNS20788.
    PubMed     Abstract available


    June 2020
  136. TAKAMI H, Khoshnood N, Bernstein M
    Preoperative factors associated with adverse events during awake craniotomy: analysis of 609 consecutive cases.
    J Neurosurg. 2020 Jun 26:1-9. doi: 10.3171/2020.4.JNS20378.
    PubMed     Abstract available


  137. ANSARI A
    Letter to the Editor. Awake craniotomy and transcortical MEP monitoring for resection of precentral gliomas.
    J Neurosurg. 2020 Jun 12:1-2. doi: 10.3171/2020.4.JNS201190.
    PubMed    


  138. CHAICHANA KL
    Erratum. Predictors of recurrence and high growth rate of residual meningiomas after subtotal resection.
    J Neurosurg. 2020 Jun 12:1. doi: 10.3171/2020.5.JNS192466.
    PubMed    


  139. SUI R, Piao H
    Letter to the Editor. Residual meningiomas.
    J Neurosurg. 2020 Jun 12:1-3. doi: 10.3171/2020.2.JNS20447.
    PubMed    


  140. GOGOS AJ, Young JS, Morshed RA, Avalos LN, et al
    Triple motor mapping: transcranial, bipolar, and monopolar mapping for supratentorial glioma resection adjacent to motor pathways.
    J Neurosurg. 2020 Jun 5:1-10. doi: 10.3171/2020.3.JNS193434.
    PubMed     Abstract available


  141. GARTON ALA, Kinslow CJ, Wang TJC
    Erratum. Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas.
    J Neurosurg. 2020 Jun 5:1. doi: 10.3171/2020.5.JNS192767.
    PubMed    


  142. KONG DS, Kim YH, Hong CK
    Optimal indications and limitations of endoscopic transorbital superior eyelid surgery for spheno-orbital meningiomas.
    J Neurosurg. 2020 Jun 5:1-8. doi: 10.3171/2020.3.JNS20297.
    PubMed     Abstract available


    May 2020
  143. YOUNG JS, Chan AK, Viner JA, Sankaran S, et al
    A Safe Transitions Pathway for post-craniotomy neurological surgery patients: high-value care that bypasses the intensive care unit.
    J Neurosurg. 2020 May 29:1-6. doi: 10.3171/2020.3.JNS192133.
    PubMed     Abstract available


  144. ABI JAOUDE S, Peyre M, Degos V, Goutagny S, et al
    Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients.
    J Neurosurg. 2020 May 22:1-9. doi: 10.3171/2020.3.JNS192382.
    PubMed     Abstract available


  145. JULIE DA, Lazow SP, Vanderbilt DB, Taube S, et al
    A matched-pair analysis of clinical outcomes after intracavitary cesium-131 brachytherapy versus stereotactic radiosurgery for resected brain metastases.
    J Neurosurg. 2020 May 15:1-8. doi: 10.3171/2020.3.JNS193419.
    PubMed     Abstract available


  146. FATIMA N, Ding VY, Han SS, Chang SD, et al
    Predictors of visual functional outcome following treatment for cavernous sinus meningioma.
    J Neurosurg. 2020 May 15:1-12. doi: 10.3171/2020.2.JNS193009.
    PubMed     Abstract available


  147. BOWDEN GN, Kim JO, Faramand A, Fallon K, et al
    Clinical dose profile of Gamma Knife stereotactic radiosurgery for extensive brain metastases.
    J Neurosurg. 2020 May 8:1-5. doi: 10.3171/2020.3.JNS193369.
    PubMed     Abstract available


  148. GARTON ALA, Kinslow CJ, Rae AI, Mehta A, et al
    Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas.
    J Neurosurg. 2020 May 8:1-11. doi: 10.3171/2020.2.JNS192767.
    PubMed     Abstract available


  149. SAITO T, Muragaki Y, Tamura M, Maruyama T, et al
    Correlation between localization of supratentorial glioma to the precentral gyrus and difficulty in identification of the motor area during awake craniotomy.
    J Neurosurg. 2020 May 1:1-10. doi: 10.3171/2020.2.JNS193471.
    PubMed     Abstract available


  150. MIRCHANDANI AS, Beyh A, Lavrador JP, Howells H, et al
    Altered corticospinal microstructure and motor cortex excitability in gliomas: an advanced tractography and transcranial magnetic stimulation study.
    J Neurosurg. 2020 May 1:1-9. doi: 10.3171/2020.2.JNS192994.
    PubMed     Abstract available


    April 2020
  151. DE VRIES F
    Letter to the Editor. Cognitive performance of patients with low-grade glioma.
    J Neurosurg. 2020 Apr 24:1-2. doi: 10.3171/2020.1.JNS2097.
    PubMed    


  152. LEE AT, Faltermeier C, Morshed RA, Young JS, et al
    The impact of high functional connectivity network hub resection on language task performance in adult low- and high-grade glioma.
    J Neurosurg. 2020 Apr 3:1-11. doi: 10.3171/2020.1.JNS192267.
    PubMed     Abstract available


  153. CHU S
    Erratum. Imaging characteristics of adult H3 K27M-mutant gliomas.
    J Neurosurg. 2020 Apr 3:1. doi: 10.3171/2020.2.JNS191920.
    PubMed    


  154. MULLER DMJ, Robe PA, Ardon H, Barkhof F, et al
    Quantifying eloquent locations for glioblastoma surgery using resection probability maps.
    J Neurosurg. 2020 Apr 3:1-11. doi: 10.3171/2020.1.JNS193049.
    PubMed     Abstract available


  155. CARRION-PENAGOS J, Zeineddine HA, Polster SP, Girard R, et al
    Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance.
    J Neurosurg. 2020 Apr 3:1-8. doi: 10.3171/2020.1.JNS193479.
    PubMed     Abstract available


    March 2020
  156. PRZYBYLOWSKI CJ, Zhao X, Baranoski JF, Borba Moreira L, et al
    Preoperative embolization versus no embolization for WHO grade I intracranial meningioma: a retrospective matched cohort study.
    J Neurosurg. 2020 Mar 27:1-8. doi: 10.3171/2020.1.JNS19788.
    PubMed     Abstract available


  157. LOHMANN S, Brix T, Varghese J, Warneke N, et al
    Development and validation of prediction scores for nosocomial infections, reoperations, and adverse events in the daily clinical setting of neurosurgical patients with cerebral and spinal tumors.
    J Neurosurg. 2020 Mar 20:1-11. doi: 10.3171/2020.1.JNS193186.
    PubMed     Abstract available


  158. ZANELLO M, Roux A, Zah-Bi G, Trancart B, et al
    Predictors of early postoperative epileptic seizures after awake surgery in supratentorial diffuse gliomas.
    J Neurosurg. 2020 Mar 13:1-10. doi: 10.3171/2020.1.JNS192774.
    PubMed     Abstract available


  159. YAMADA T, Tsuji S, Nakamura S, Egashira Y, et al
    Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma.
    J Neurosurg. 2020 Mar 13:1-10. doi: 10.3171/2019.12.JNS192682.
    PubMed     Abstract available


  160. DALLE ORE CL, Magill ST, Rodriguez Rubio R, Shahin MN, et al
    Hyperostosing sphenoid wing meningiomas: surgical outcomes and strategy for bone resection and multidisciplinary orbital reconstruction.
    J Neurosurg. 2020 Mar 6:1-10. doi: 10.3171/2019.12.JNS192543.
    PubMed     Abstract available


    February 2020
  161. RUTLAND JW, Loewenstern J, Ranti D, Tsankova NM, et al
    Analysis of 7-tesla diffusion-weighted imaging in the prediction of pituitary macroadenoma consistency.
    J Neurosurg. 2020 Feb 28:1-9. doi: 10.3171/2019.12.JNS192940.
    PubMed     Abstract available


  162. GOLUB D, Hyde J, Dogra S, Nicholson J, et al
    Intraoperative MRI versus 5-ALA in high-grade glioma resection: a network meta-analysis.
    J Neurosurg. 2020 Feb 21:1-15. doi: 10.3171/2019.12.JNS191203.
    PubMed     Abstract available


  163. ISHI Y, Yamaguchi S, Hatanaka KC, Okamoto M, et al
    Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients.
    J Neurosurg. 2020 Feb 14:1-9. doi: 10.3171/2019.12.JNS192155.
    PubMed     Abstract available


  164. YAMASHITA D, Bernstock JD, Elsayed G, Sadahiro H, et al
    Targeting glioma-initiating cells via the tyrosine metabolic pathway.
    J Neurosurg. 2020 Feb 14:1-12. doi: 10.3171/2019.11.JNS192028.
    PubMed     Abstract available


  165. ALHILALI LM, Little AS, Yuen KCJ, Lee J, et al
    Early postoperative MRI and detection of residual adenoma after transsphenoidal pituitary surgery.
    J Neurosurg. 2020 Feb 7:1-10. doi: 10.3171/2019.11.JNS191845.
    PubMed     Abstract available


    January 2020
  166. SUERO MOLINA E, Brokinkel B
    Letter to the Editor. Sodium fluorescein versus 5-aminolevulinic acid to visualize high-grade gliomas.
    J Neurosurg. 2020 Jan 24:1-3. doi: 10.3171/2019.12.JNS193180.
    PubMed    


  167. SCHIPMANN S, Muther M, Stogbauer L, Zimmer S, et al
    Combination of ALA-induced fluorescence-guided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control.
    J Neurosurg. 2020 Jan 24:1-11. doi: 10.3171/2019.11.JNS192443.
    PubMed     Abstract available


  168. PRIETO R, Pascual JM
    Cushing's dogged struggle against death: the astonishing case of a patient under cardiac arrest surviving craniopharyngioma surgery.
    J Neurosurg. 2020 Jan 17:1-10. doi: 10.3171/2019.11.JNS192487.
    PubMed     Abstract available


  169. LIU D, Chen J, Hu X, Hu G, et al
    Contralesional homotopic functional plasticity in patients with temporal glioma.
    J Neurosurg. 2020 Jan 10:1-9. doi: 10.3171/2019.11.JNS191982.
    PubMed     Abstract available


  170. MATERI J, Mampre D, Ehresman J, Rincon-Torroella J, et al
    Predictors of recurrence and high growth rate of residual meningiomas after subtotal resection.
    J Neurosurg. 2020 Jan 3:1-7. doi: 10.3171/2019.10.JNS192466.
    PubMed     Abstract available


  171. PARK SH, Kim MJ, Jung HH, Chang WS, et al
    Safety and feasibility of multiple blood-brain barrier disruptions for the treatment of glioblastoma in patients undergoing standard adjuvant chemotherapy.
    J Neurosurg. 2020 Jan 3:1-9. doi: 10.3171/2019.10.JNS192206.
    PubMed     Abstract available


    December 2019
  172. BERGER A, Tzarfati G, Costa M, Serafimova M, et al
    Incidence and impact of stroke following surgery for low-grade gliomas.
    J Neurosurg. 2019 Dec 27:1-9. doi: 10.3171/2019.10.JNS192301.
    PubMed     Abstract available


  173. RUSTEMI O, Raneri F, Beggio G, Volpin L, et al
    Letter to the Editor. Cost-effectiveness of sodium fluorescein in high-grade gliomas.
    J Neurosurg. 2019 Dec 13:1-2. doi: 10.3171/2019.10.JNS192817.
    PubMed    


  174. ARRIETA VA, Iwamoto F, Lukas RV, Sachdev S, et al
    Can patient selection and neoadjuvant administration resuscitate PD-1 inhibitors for glioblastoma?
    J Neurosurg. 2019 Dec 6:1-6. doi: 10.3171/2019.9.JNS192523.
    PubMed    


    November 2019
  175. TULEASCA C, Giammattei L, Daniel RT, Levivier M, et al
    Letter to the Editor. Multimodal management for benign skull base meningiomas.
    J Neurosurg. 2019 Nov 15:1-2. doi: 10.3171/2019.6.JNS191682.
    PubMed    


  176. QIU T, Chanchotisatien A, Qin Z, Wu J, et al
    Imaging characteristics of adult H3 K27M-mutant gliomas.
    J Neurosurg. 2019 Nov 15:1-9. doi: 10.3171/2019.9.JNS191920.
    PubMed     Abstract available


  177. RIJNEN SJM, Kaya G, Gehring K, Verheul JB, et al
    Cognitive functioning in patients with low-grade glioma: effects of hemispheric tumor location and surgical procedure.
    J Neurosurg. 2019 Nov 15:1-12. doi: 10.3171/2019.8.JNS191667.
    PubMed     Abstract available


  178. PRIETO R, Pascual JM, Barrios L
    Charles H. Frazier's craniopharyngioma treatment: the pivotal role of the transfrontal approach.
    J Neurosurg. 2019 Nov 8:1-14. doi: 10.3171/2019.8.JNS191508.
    PubMed     Abstract available


  179. BERNSTEIN A, Mrowczynski OD, Greene A, Ryan S, et al
    Dual BRAF/MEK therapy in BRAF V600E-mutated primary brain tumors: a case series showing dramatic clinical and radiographic responses and a reduction in cutaneous toxicity.
    J Neurosurg. 2019 Nov 1:1-6. doi: 10.3171/2019.8.JNS19643.
    PubMed     Abstract available


  180. PRIETO R, Pascual JM
    Letter to the Editor. The craniopharyngioma-hypothalamus relationship.
    J Neurosurg. 2019 Nov 1:1-2. doi: 10.3171/2019.7.JNS191780.
    PubMed    


    October 2019
  181. VOGELBAUM MA
    Editorial. Considering the role of surgery for low-grade glioma in the molecular genetic era.
    J Neurosurg. 2019 Oct 25:1-3. doi: 10.3171/2019.7.JNS191747.
    PubMed    


  182. KAVOURIDIS VK, Boaro A, Dorr J, Cho EY, et al
    Contemporary assessment of extent of resection in molecularly defined categories of diffuse low-grade glioma: a volumetric analysis.
    J Neurosurg. 2019 Oct 25:1-11. doi: 10.3171/2019.6.JNS19972.
    PubMed     Abstract available


  183. YOUNGBLOOD MW, Duran D, Montejo JD, Li C, et al
    Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas.
    J Neurosurg. 2019 Oct 25:1-10. doi: 10.3171/2019.8.JNS191266.
    PubMed     Abstract available


  184. SMITH N, Saunders D, Jensen RL, Towner RA, et al
    Association of decreased levels of lipopolysaccharide-binding protein with OKN-007-induced regression of tumor growth in an F98 rat glioma model.
    J Neurosurg. 2019 Oct 18:1-9. doi: 10.3171/2019.7.JNS182435.
    PubMed     Abstract available


  185. YOMO S, Oda K, Oguchi K
    Single- versus 2-session Gamma Knife surgery for symptomatic midsize brain metastases: a propensity score-matched analysis.
    J Neurosurg. 2019 Oct 18:1-9. doi: 10.3171/2019.7.JNS191193.
    PubMed     Abstract available


  186. IBRAHIM AN, Yamashita D, Anderson JC, Abdelrashid M, et al
    Intratumoral spatial heterogeneity of BTK kinomic activity dictates distinct therapeutic response within a single glioblastoma tumor.
    J Neurosurg. 2019 Oct 18:1-12. doi: 10.3171/2019.7.JNS191376.
    PubMed     Abstract available


  187. SCHNEIDER M, Guresir A, Borger V, Hamed M, et al
    Preoperative tumor-associated epilepsy in patients with supratentorial meningioma: factors influencing seizure outcome after meningioma surgery.
    J Neurosurg. 2019 Oct 11:1-7. doi: 10.3171/2019.7.JNS19455.
    PubMed     Abstract available


  188. HANSEN RW, Pedersen CB, Halle B, Korshoej AR, et al
    Comparison of 5-aminolevulinic acid and sodium fluorescein for intraoperative tumor visualization in patients with high-grade gliomas: a single-center retrospective study.
    J Neurosurg. 2019 Oct 4:1-8. doi: 10.3171/2019.6.JNS191531.
    PubMed     Abstract available


  189. JARVIS CA, Bakhsheshian J, Ding L, Wen T, et al
    Increased complication and mortality among non-index hospital readmissions after brain tumor resection is associated with low-volume readmitting hospitals.
    J Neurosurg. 2019 Oct 4:1-13. doi: 10.3171/2019.6.JNS183469.
    PubMed     Abstract available


    September 2019
  190. MARHOLD F, Mercea PA, Scheichel F, Berghoff AS, et al
    Detailed analysis of 5-aminolevulinic acid induced fluorescence in different brain metastases at two specialized neurosurgical centers: experience in 157 cases.
    J Neurosurg. 2019 Sep 27:1-12. doi: 10.3171/2019.6.JNS1997.
    PubMed     Abstract available


  191. ZHU P, Du XL, Blanco AI, Ballester LY, et al
    Impact of facility type and volume in low-grade glioma outcomes.
    J Neurosurg. 2019 Sep 27:1-11. doi: 10.3171/2019.6.JNS19409.
    PubMed     Abstract available


    May 2019
  192. GUO X, Yao S, Xing B
    Letter to the Editor. Is 7-Tesla MRI necessary in the assessment of microstructural injury to visual pathways due to pituitary adenomas?
    J Neurosurg. 2019 May 17:1-3. doi: 10.3171/2019.2.JNS19413.
    PubMed    


    February 2019
  193. KO CC, Chen TY, Lim SW, Kuo YT, et al
    Prediction of recurrence in solid nonfunctioning pituitary macroadenomas: additional benefits of diffusion-weighted MR imaging.
    J Neurosurg. 2019 Feb 1:1-9. doi: 10.3171/2018.10.JNS181783.
    PubMed     Abstract available


    January 2019
  194. RUTLAND JW, Padormo F, Yim CK, Yao A, et al
    Quantitative assessment of secondary white matter injury in the visual pathway by pituitary adenomas: a multimodal study at 7-Tesla MRI.
    J Neurosurg. 2019 Jan 18:1-10. doi: 10.3171/2018.9.JNS182022.
    PubMed     Abstract available


  195. RINALDO L, Brown DA, Bhargav AG, Rusheen AE, et al
    Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature.
    J Neurosurg. 2019 Jan 4:1-12. doi: 10.3171/2018.7.JNS181175.
    PubMed     Abstract available


    December 2018
  196. MUNIER SM, Hargreaves EL, Patel NV, Danish SF, et al
    Ablation dynamics of subsequent thermal doses delivered to previously heat-damaged tissue during magnetic resonance-guided laser-induced thermal therapy.
    J Neurosurg. 2018 Dec 21:1-8. doi: 10.3171/2018.7.JNS18886.
    PubMed     Abstract available



  197. Intraoperative near-infrared imaging with receptor-specific versus passive delivery of fluorescent agents in pituitary adenomas.
    J Neurosurg. 2018 Dec 14:1-11. doi: 10.3171/2018.7.JNS181642.
    PubMed     Abstract available


    October 2018

  198. ReStNeuMap: a tool for automatic extraction of resting-state functional MRI networks in neurosurgical practice.
    J Neurosurg. 2018 Oct 1:1-8. doi: 10.3171/2018.4.JNS18474.
    PubMed     Abstract available


    September 2018
  199. MUHLESTEIN WE, Akagi DS, McManus AR, Chambless LB, et al
    Machine learning ensemble models predict total charges and drivers of cost for transsphenoidal surgery for pituitary tumor.
    J Neurosurg. 2018 Sep 21:1-10. doi: 10.3171/2018.4.JNS18306.
    PubMed     Abstract available


    May 2018
  200. LIN M, Wedemeyer MA, Bradley D, Donoho DA, et al
    Long-term surgical outcomes following transsphenoidal surgery in patients with Rathke's cleft cysts.
    J Neurosurg. 2018 May 18:1-7. doi: 10.3171/2017.11.JNS171498.
    PubMed     Abstract available


  201. WANG Z, Xing B
    Letter to the Editor. Detection of MRI-negative Cushing's disease by FLAIR imaging: is it reliable?
    J Neurosurg. 2018 May 4:1-2. doi: 10.3171/2017.12.JNS173041.
    PubMed    


    April 2018
  202. SIVAKUMAR W, Jensen M, Martinez J, Tanana M, et al
    Intravenous acetaminophen for postoperative supratentorial craniotomy pain: a prospective, randomized, double-blinded, placebo-controlled trial.
    J Neurosurg. 2018 Apr 20:1-7. doi: 10.3171/2017.10.JNS171464.
    PubMed     Abstract available


    March 2018
  203. LI D, Jiao YM, Wang L, Lin FX, et al
    Surgical outcome of motor deficits and neurological status in brainstem cavernous malformations based on preoperative diffusion tensor imaging: a prospective randomized clinical trial.
    J Neurosurg. 2018 Mar 16:1-16. doi: 10.3171/2017.8.JNS17854.
    PubMed     Abstract available


    December 2017
  204. MAYBERG M, Reintjes S, Patel A, Moloney K, et al
    Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
    J Neurosurg. 2017 Dec 22:1-10. doi: 10.3171/2017.6.JNS17635.
    PubMed     Abstract available


    October 2017
  205. POMERANIEC IJ, Kano H, Xu Z, Nguyen B, et al
    Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study.
    J Neurosurg. 2017 Oct 27:1-10. doi: 10.3171/2017.5.JNS163069.
    PubMed     Abstract available


  206. CHATAIN GP, Patronas N, Smirniotopoulos JG, Piazza M, et al
    Potential utility of FLAIR in MRI-negative Cushing's disease.
    J Neurosurg. 2017 Oct 13:1-9. doi: 10.3171/2017.4.JNS17234.
    PubMed     Abstract available


    June 2017
  207. ESEONU CI, Eguia F, Garcia O, Kaplan PW, et al
    Comparative analysis of monotherapy versus duotherapy antiseizure drug management for postoperative seizure control in patients undergoing an awake craniotomy.
    J Neurosurg. 2017 Jun 16:1-7. doi: 10.3171/2017.1.JNS162913.
    PubMed     Abstract available


    April 2017
  208. GESSLER F, Bruder M, Duetzmann S, Tritt S, et al
    Risk factors governing the development of cerebral vein and dural sinus thrombosis after craniotomy in patients with intracranial tumors.
    J Neurosurg. 2017 Apr 7:1-7. doi: 10.3171/2016.11.JNS161871.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: